Crescent Capital
Private Equity Est. 2000
- Type
- Private Equity
- HQ
- Sydney, NSW, Australia
- Founded
- 2000
- Last fundraise
- 2026 (AUD 1.3B target)
About
Crescent Capital Partners is a Sydney-based private equity firm investing in middle market companies located in Australia and New Zealand with enterprise values between A$50 million and A$300 million. Formed in 2000, Crescent has established itself as one of Australasia's top mid-market PE firms. Its last three funds ranked as top quartile global funds (measured in either USD or AUD by Cambridge Associates). Crescent Capital focuses on high growth companies and sectors, or industries that are undergoing structural change or that lend themselves to consolidation. Crescent's role is to accelerate and support the senior management teams of these businesses in reaching their aspirational targets and goals. Crescent has particular experience and skills in financial services, healthcare, branded and industrial businesses. Unlike many other private equity funds, all of Crescent's team have experience in strategy consulting and/or direct hands on operational roles.
Strategies
Buyout
Growth Equity
Investment Focus
Investment size
USD 10M - USD 50M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Investment Stages
Stages
Growth
Investment Geographies
Primary Markets
Australia
Coverage
Global Regions
Oceania
Coverage is a guide only.
Location
Office Presence
1 country
Australia
1 known office
Sydney, NSW, Australia (HQ)
Fundraising
Crescent Capital Partners VIII
2026 - Target raise
AUD 1.3B (Target Raise)
source Crescent Capital Partners VII
2023
AUD 1B
source Crescent Capital Partners VI
2018
AUD 800M
source Crescent Capital Partners V
2015
AUD 675M
source Crescent Capital Partners IV
2012
AUD 526M
source Crescent Capital Partners III
2006
AUD 400M
source Deals & Activity
Deals, last 12 months
0
None led
Deals, last 36 months
0
None led
Exits, last 36 months
1
1 on record
Exits
- ClearView Wealth · sold to Zurich Financial Services Australia Feb 2026
Similar investors
Bioscience Managers
Bioscience Managers is an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare. Bioscience Managers invests in private and public healthcare companies with clear technological and market advantages in any territory, where we are confident that our engagement with management will deliver commercial success and returns for investors. We are both geographically and therapeutically agnostic. We invest in public and private healthcare companies in any territory which work in therapeutics, medical devices, diagnostics or digital health, which are in or near clinical development or commercialisation. Our strategy is to take a a meaningful stake in our investee companies, including board representation, advisory and or hands-on-roles to augment existing skills and to build a proactive and supportive relationships. We are part of the PhillipCapital Group, which has £30bn under management across 16 offices around the world.
Portland House Group
Portland House Group is the Melbourne investment vehicle of the Hains family. Established by David Hains, the group has invested family capital across global equities, fixed income, property and external funds.
Tanarra
Tanarra is a diversified investment manager investing for superannuation funds, financial institutions and family offices across private and public equity, debt, venture capital and special situations; its venture activities include Tanarra Ventures and Tin Alley Ventures.
Allectus Capital
Allectus Capital is an investor in disruptive technology companies in the Asia Pacific and United Kingdom. We invest in both listed and unlisted companies and partner with and support our investment companies through regular management contact and active communication across our portfolio. Allectus Capital likes to be the first investor in our high conviction portfolio investments. However, we invest across early to late stage deals ranging from very small to very large. Our first cheque is usually $300k - $3m AUD and we look to invest in subsequent rounds where they have gained traction.
Allectus Capital is owned by ICM, an international fund manager based in Bermuda, and UIL Limited.
BMH Capital
BMH Capital provides corporate and venture advisory and capital-markets services; BMH Ventures invests from seed through late-stage private rounds.
Lederer Group
Lederer (Group) is an Australian-owned family business founded by Paul Lederer. It describes a property investment portfolio and a focus on creating communities within its buildings.
Other Private Equity Firms Headquartered in Australia
IFM Investors
IFM Investors is one of Australia's leading investors, with a strong track record of investment across four key asset classes: debt investments, listed equities, infrastructure and private equity. With respect to private equity, IFM looks for minority or majority investments in Australian and New Zealand mid-market ($50m to $300m valuation) growth companies. IFM is sector agnostic, however particularly likes healthcare, consumer brands, technology and business services. IFM Investors is owned by 27 Australian superannuation funds.
Regal Partners
Regal Partners Limited is an ASX-listed, specialist alternative investment manager providing investors with access to a diverse range of strategies covering hedge funds, private markets and real assets.
Ellerston Capital
Our investment approach is designed to focus on opportunities the market may have overlooked, exploiting inefficiencies by identifying stocks that are temporarily misunderstood and fundamentally mispriced.
Our funds target a range of strategies, from large and small capitalisation Australian equity, global long short to Australian market neutral and private equity.
Our clients include Government, industry and corporate superannuation funds, international funds as well as individual investors via leading investment administration platforms and a growing number of financial advisors.
Pacific Equity Partners
Pacific Equity Partners (PEP) is the largest private equity firm in Australia and New Zealand. PEP invests through buyouts and growth capital into a wide range of industries including industrial services, energy, consumer products, entertainment and financial services. PEP prefers to invest in companies with major operations in Australia or New Zealand and with Enterprise Values between A$200m and A$1bn. It typically invests for between three and six years. PEP was founded in 1998 by senior Australian partners of the leading strategy consulting firm Bain & Co.
BGH Capital
BGH Capital is an Australian private equity firm founded in 2017. It focuses on buyout and growth investments across a range of industries in Australia and New Zealand.
CP2
CP2 is a specialist infrastructure investment manager and has been a global leader in infrastructure investing and asset management for over 25 years. We invest in core infrastructure assets that provide secure, stable, inflation-protected cash flows over the long term, and often partners with like-minded investors such as sovereign wealth funds. CP2 focuses on specialist infrastructure; transport including roads, airport, railway, and ports; utilities including power, water, and communication; and social including health, schools, and law and order. The firm does not invest in generation assets, fringe infrastructure including car parks and satellites, externally managed vehicles, constructor or investment bank sponsored greenfield projects, and social infrastructure. The firm invests in both listed and unlisted opportunities.